BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zamboulis A, Nanaki S, Michailidou G, Koumentakou I, Lazaridou M, Ainali NM, Xanthopoulou E, Bikiaris DN. Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments. Polymers (Basel) 2020;12:E1519. [PMID: 32650536 DOI: 10.3390/polym12071519] [Cited by in Crossref: 12] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Lazaridou M, Bikiaris DN, Lamprou DA. 3D Bioprinted Chitosan-Based Hydrogel Scaffolds in Tissue Engineering and Localised Drug Delivery. Pharmaceutics 2022;14:1978. [PMID: 36145727 DOI: 10.3390/pharmaceutics14091978] [Reference Citation Analysis]
2 Martinez Junior AM, Lima AMF, Martins GO, Tiera VAO, Benderdour M, Fernandes JC, Tiera MJ. Impact of Degree of Ionization and PEGylation on the Stability of Nanoparticles of Chitosan Derivatives at Physiological Conditions. Mar Drugs 2022;20:476. [PMID: 35892944 DOI: 10.3390/md20080476] [Reference Citation Analysis]
3 Feng M, Hu X, Yin Y, Liang Y, Niu J, Yao J. Structural Analysis of Oxidized Sucrose and Its Application as a Crease-Resistant Crosslinking Agent. Polymers 2022;14:2842. [DOI: 10.3390/polym14142842] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Sadasivam R, Packirisamy G, Goswami M. Biocompatible soft hydrogel lens as topical implants for diabetic retinopathy. Materials Letters 2022;318:132174. [DOI: 10.1016/j.matlet.2022.132174] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Akulo KA, Adali T, Moyo MTG, Bodamyali T. Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy. Polymers (Basel) 2022;14:2359. [PMID: 35745935 DOI: 10.3390/polym14122359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zaghloul N, El Hoffy NM, Mahmoud AA, Elkasabgy NA. Cyclodextrin Stabilized Freeze-Dried Silica/Chitosan Nanoparticles for Improved Terconazole Ocular Bioavailability. Pharmaceutics 2022;14:470. [PMID: 35335847 DOI: 10.3390/pharmaceutics14030470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Das S, Saha D, Majumdar S, Giri L. Imaging Methods for the Assessment of a Complex Hydrogel as an Ocular Drug Delivery System for Glaucoma Treatment: Opportunities and Challenges in Preclinical Evaluation. Mol Pharm 2022. [PMID: 35179892 DOI: 10.1021/acs.molpharmaceut.1c00831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wadhwa A, Jadhav C, Yadav KS. Bimatoprost: Promising novel drug delivery systems in treatment of glaucoma. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Alkabli J. Progress in preparation of thiolated, crosslinked, and imino-chitosan derivatives targeting specific applications. European Polymer Journal 2022;165:110998. [DOI: 10.1016/j.eurpolymj.2022.110998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Allyn MM, Luo RH, Hellwarth EB, Swindle-reilly KE. Considerations for Polymers Used in Ocular Drug Delivery. Front Med 2022;8:787644. [DOI: 10.3389/fmed.2021.787644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zamboulis A, Michailidou G, Koumentakou I, Bikiaris DN. Polysaccharide 3D Printing for Drug Delivery Applications. Pharmaceutics 2022;14:145. [PMID: 35057041 DOI: 10.3390/pharmaceutics14010145] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
12 Niculescu AG, Grumezescu AM. Applications of Chitosan-Alginate-Based Nanoparticles-An Up-to-Date Review. Nanomaterials (Basel) 2022;12:186. [PMID: 35055206 DOI: 10.3390/nano12020186] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
13 Parvez S, Kaushik M, Ali M, Alam MM, Ali J, Tabassum H, Kaushik P. Dodging blood brain barrier with "nano" warriors: Novel strategy against ischemic stroke. Theranostics 2022;12:689-719. [PMID: 34976208 DOI: 10.7150/thno.64806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Dalvin LA. Thiolated Chitosan-carboxymethyl Dextran Nanoparticles: Improving Intravitreal Drug Bioavailability for Retinoblastoma. J Ophthalmic Vis Res 2022;17:1-3. [PMID: 35194489 DOI: 10.18502/jovr.v17i1.10163] [Reference Citation Analysis]
15 Nayak R, Kar B, Ghosh G, Rath G. Current trends in chitosan based nanopharmaceuticals for topical vaginal therapies. Int J Biol Macromol 2021;193:2140-52. [PMID: 34780894 DOI: 10.1016/j.ijbiomac.2021.11.045] [Reference Citation Analysis]
16 Sosnik A, Shabo RB, Halamish HM. Cannabidiol-Loaded Mixed Polymeric Micelles of Chitosan/Poly(Vinyl Alcohol) and Poly(Methyl Methacrylate) for Trans-Corneal Delivery. Pharmaceutics 2021;13:2142. [PMID: 34959427 DOI: 10.3390/pharmaceutics13122142] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
17 Michailidou G, Koukaras EN, Bikiaris DN. Vanillin chitosan miscible hydrogel blends and their prospects for 3D printing biomedical applications. Int J Biol Macromol 2021;192:1266-75. [PMID: 34687759 DOI: 10.1016/j.ijbiomac.2021.10.093] [Reference Citation Analysis]
18 Popova EV, Tikhomirova VE, Beznos OV, Chesnokova NB, Grigoriev YV, Klyachko NL, Kost OA. Chitosan-covered calcium phosphate particles as a drug vehicle for delivery to the eye. Nanomedicine 2021;40:102493. [PMID: 34775060 DOI: 10.1016/j.nano.2021.102493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Burhan AM, Klahan B, Cummins W, Andrés-Guerrero V, Byrne ME, O'Reilly NJ, Chauhan A, Fitzhenry L, Hughes H. Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan. Pharmaceutics 2021;13:1685. [PMID: 34683978 DOI: 10.3390/pharmaceutics13101685] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Dandamudi M, McLoughlin P, Behl G, Rani S, Coffey L, Chauhan A, Kent D, Fitzhenry L. Chitosan-Coated PLGA Nanoparticles Encapsulating Triamcinolone Acetonide as a Potential Candidate for Sustained Ocular Drug Delivery. Pharmaceutics 2021;13:1590. [PMID: 34683883 DOI: 10.3390/pharmaceutics13101590] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
21 N G O, H P S AK, El-Bahy SM, Rafatullah M, Abdullah CK, El-Bahy ZM, Grace OF. Supercritical Carbon Dioxide Isolation of Cellulose Nanofibre and Enhancement Properties in Biopolymer Composites. Molecules 2021;26:5276. [PMID: 34500709 DOI: 10.3390/molecules26175276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Schneider-Futschik EK, Reyes-Ortega F. Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders. Pharmaceutics 2021;13:1157. [PMID: 34452117 DOI: 10.3390/pharmaceutics13081157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Lazaridou M, Nanaki S, Zamboulis A, Papoulia C, Chrissafis K, Klonos PA, Kyritsis A, Vergkizi-Nikolakaki S, Kostoglou M, Bikiaris DN. Super absorbent chitosan-based hydrogel sponges as carriers for caspofungin antifungal drug. Int J Pharm 2021;606:120925. [PMID: 34303816 DOI: 10.1016/j.ijpharm.2021.120925] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Rubenicia AML, Cubillan LDP, Sicam VADP, Macabeo APG, Villaflores OB, Castillo AL. Intraocular Pressure Reduction Effect of 0.005% Latanoprost Eye Drops in a Hyaluronic Acid-Chitosan Nanoparticle Drug Delivery System in Albino Rabbits. Transl Vis Sci Technol 2021;10:2. [PMID: 34003979 DOI: 10.1167/tvst.10.4.2] [Reference Citation Analysis]
25 Fang G, Yang X, Wang Q, Zhang A, Tang B. Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases. Mater Sci Eng C Mater Biol Appl 2021;127:112212. [PMID: 34225864 DOI: 10.1016/j.msec.2021.112212] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Uchegbu IF, Breznikar J, Zaffalon A, Odunze U, Schätzlein AG. Polymeric Micelles for the Enhanced Deposition of Hydrophobic Drugs into Ocular Tissues, without Plasma Exposure. Pharmaceutics 2021;13:744. [PMID: 34069936 DOI: 10.3390/pharmaceutics13050744] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
27 Nasution H, Olaiya NG, Haafiz MKM, Abdullah CK, Bakar SA, Olaiya FG, Mohamed A, H. P. S. AK. The role of amphiphilic chitosan in hybrid nanocellulose–reinforced polylactic acid biocomposite. Polym Adv Technol 2021;32:3446-57. [DOI: 10.1002/pat.5355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Zhai Z, Cheng Y, Hong J. Nanomedicines for the treatment of glaucoma: Current status and future perspectives. Acta Biomater 2021;125:41-56. [PMID: 33601065 DOI: 10.1016/j.actbio.2021.02.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Lanier OL, Manfre MG, Bailey C, Liu Z, Sparks Z, Kulkarni S, Chauhan A. Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations. AAPS PharmSciTech 2021;22:107. [PMID: 33719019 DOI: 10.1208/s12249-021-01977-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
30 Giacone DV, Dartora VFMC, de Matos JKR, Passos JS, Miranda DAG, de Oliveira EA, Silveira ER, Costa-Lotufo LV, Maria-Engler SS, Lopes LB. Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models. Int J Biol Macromol 2020;165:1055-65. [PMID: 32987080 DOI: 10.1016/j.ijbiomac.2020.09.167] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
31 Shahab MS, Rizwanullah M, Alshehri S, Imam SS. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments. Int J Biol Macromol 2020;163:2392-404. [PMID: 32979440 DOI: 10.1016/j.ijbiomac.2020.09.185] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]